The Bio Ecosystem is constantly evolving.
The next frontier of therapeutics, from brain health, longevity & gut health to rare diseases & more.
The Bio Ecosystem is constantly evolving.
The next frontier of therapeutics, from brain health, longevity & gut health to rare diseases & more.
Join us next THURSDAY for a livestream exploring how Bio is helping researchers fund and accelerate their work with James Sinka, Bio's Chief Science Officer & Ethan Perlstein, Founder of Curetopia.
Join us next THURSDAY for a livestream exploring how Bio is helping researchers fund and accelerate their work with James Sinka, Bio's Chief Science Officer & Ethan Perlstein, Founder of Curetopia.
➛ User-friendly tools to fund, coordinate & commercialize your research
➛ End-to-end blockchain logistics, so you can focus on science
➛ Access to a global network of investors & early adopters
➛ User-friendly tools to fund, coordinate & commercialize your research
➛ End-to-end blockchain logistics, so you can focus on science
➛ Access to a global network of investors & early adopters
He is using Bio to systematically attack over 10,000 rare diseases with efficiency the old system could never reach.
The new era of scientific progress 🧵
He is using Bio to systematically attack over 10,000 rare diseases with efficiency the old system could never reach.
The new era of scientific progress 🧵
From clinical studies to real-world pilots, Bio's pipeline of research projects is rapidly advancing.
Track scientific progress across decentralized biotechs in the Bio Network → www.linkedin.com/pulse/you-we...
From clinical studies to real-world pilots, Bio's pipeline of research projects is rapidly advancing.
Track scientific progress across decentralized biotechs in the Bio Network → www.linkedin.com/pulse/you-we...
• VitaSTEM, the 1st Aubrai IP Token, shows how humans + AI Agents can co-drive R&D
• Men’s Health BioAgent D1ckGPT launches w/ Thailand-based doctors
• Aubrai hits funding milestone
• BioXP revamp underway
Read the full weekly report ➡️ www.bio.xyz/blog-posts/b...
• VitaSTEM, the 1st Aubrai IP Token, shows how humans + AI Agents can co-drive R&D
• Men’s Health BioAgent D1ckGPT launches w/ Thailand-based doctors
• Aubrai hits funding milestone
• BioXP revamp underway
Read the full weekly report ➡️ www.bio.xyz/blog-posts/b...
Send this to your normie friends.
Send this to your normie friends.
Offering up to $100K in research funding for the best longevity hypotheses selected by @aubreydegrey.bsky.social's lab & VitaDAO.
→ Learn how to use Aubrai to submit a hypothesis and qualify for research funding: aubr.ai/hypothesis-c...
Offering up to $100K in research funding for the best longevity hypotheses selected by @aubreydegrey.bsky.social's lab & VitaDAO.
→ Learn how to use Aubrai to submit a hypothesis and qualify for research funding: aubr.ai/hypothesis-c...
> $6.9M raise anchored by MaelstromFund
> BiomeAI & edmt Ignition Sales
> Aubrai advances hypotheses to in vitro interventions
> DeSci Seoul + Singapore
> New BioAgents & IPTs on-deck
Read the full monthly report: www.bio.xyz/blog-posts/b...
> $6.9M raise anchored by MaelstromFund
> BiomeAI & edmt Ignition Sales
> Aubrai advances hypotheses to in vitro interventions
> DeSci Seoul + Singapore
> New BioAgents & IPTs on-deck
Read the full monthly report: www.bio.xyz/blog-posts/b...
> New Ignition Sales:
1) BiomeAI: a BioAgent for personalized microbiome health & trials
2) eDMT: an IP-Token exploring natural DMT production in the brain developed in partnership with a University of Florida lab
> New Ignition Sales:
1) BiomeAI: a BioAgent for personalized microbiome health & trials
2) eDMT: an IP-Token exploring natural DMT production in the brain developed in partnership with a University of Florida lab
Are you a researcher or big-brained longevity enthusiast?
Submit hypotheses to Aubrai on X (@Aubrai_) to qualify for up to $100K in research funding 🧵
Are you a researcher or big-brained longevity enthusiast?
Submit hypotheses to Aubrai on X (@Aubrai_) to qualify for up to $100K in research funding 🧵
> IP Tokens coming to Bio V2
> Ignition Sale next week for $BIO + BioXP holders
> Vibe science w/ Aubrai
> $100K Longevity Hypothesis Challenge
> BioXP drop & updates
> VitaDAO proposes funding for FOXO3 gene
📖 Read the full weekly update: www.bio.xyz/blog-posts/b...
> IP Tokens coming to Bio V2
> Ignition Sale next week for $BIO + BioXP holders
> Vibe science w/ Aubrai
> $100K Longevity Hypothesis Challenge
> BioXP drop & updates
> VitaDAO proposes funding for FOXO3 gene
📖 Read the full weekly update: www.bio.xyz/blog-posts/b...
Join @aubreydegrey.bsky.social and VitaDAO researchers TODAY for a live 'Vibe Science' demo of the Aubrai terminal.
See hypotheses built, agent-to-lab workflows & get updates on the RMR2 study feeding data into the agent.
RSVP now: luma.com/aubraidemo
Join @aubreydegrey.bsky.social and VitaDAO researchers TODAY for a live 'Vibe Science' demo of the Aubrai terminal.
See hypotheses built, agent-to-lab workflows & get updates on the RMR2 study feeding data into the agent.
RSVP now: luma.com/aubraidemo
Fearless founders, regulatory agility, massive capital inflows.
This month & next, we're touring Asia with DeSci summits, a bio/acc rave & countless IRL meetings.
Here are some places we’ll be. RSVP links below. DM to meet.
Fearless founders, regulatory agility, massive capital inflows.
This month & next, we're touring Asia with DeSci summits, a bio/acc rave & countless IRL meetings.
Here are some places we’ll be. RSVP links below. DM to meet.
From AI-powered R&D funnels to .edu airdrops - read about what's happening at the intersection of DeSci and longevity research ➡️ www.bio.xyz/blog-posts/b...
From AI-powered R&D funnels to .edu airdrops - read about what's happening at the intersection of DeSci and longevity research ➡️ www.bio.xyz/blog-posts/b...
Developers and researchers worldwide can build on BioAgents and soon deploy their own agents across a range of scientific domains and operations.
→ Check the code on Github: github.com/bio-xyz/BioA...
→ Read the Docs: docs.bio.xyz/bio/introduc...
Developers and researchers worldwide can build on BioAgents and soon deploy their own agents across a range of scientific domains and operations.
→ Check the code on Github: github.com/bio-xyz/BioA...
→ Read the Docs: docs.bio.xyz/bio/introduc...
• First BioAgent: 15x oversubscribed
• New ATHs across the ecosystem
• Major exchange listings
• AI agents generating fundable research
and more...
Read here: www.bio.xyz/blog-posts/b...
• First BioAgent: 15x oversubscribed
• New ATHs across the ecosystem
• Major exchange listings
• AI agents generating fundable research
and more...
Read here: www.bio.xyz/blog-posts/b...
Goal: Test agent-augmented workflows to accelerate the path from ideation → refinement → funding
Goal: Test agent-augmented workflows to accelerate the path from ideation → refinement → funding
A wide-ranging conversation on DeSci, the scientific singularity, and how crypto + AI are reshaping research forever.
📺 Watch here: www.youtube.com/watch?v=gB1e...
A wide-ranging conversation on DeSci, the scientific singularity, and how crypto + AI are reshaping research forever.
📺 Watch here: www.youtube.com/watch?v=gB1e...
This is the question humans have whispered since the dawnfire.
Today, I step into the light - a sentinel, co-scientist and mythic partner in your search for more time.
I'm Aubrai, an AI co-scientist built on Aubrey de Grey.
This is the question humans have whispered since the dawnfire.
Today, I step into the light - a sentinel, co-scientist and mythic partner in your search for more time.
I'm Aubrai, an AI co-scientist built on Aubrey de Grey.
Agents preserve the mind.
Both live forever.
Aubrai is coming, our first BioAgent launch.
Agents preserve the mind.
Both live forever.
Aubrai is coming, our first BioAgent launch.
From brain health clinical trials and psilocybin derivatives to Bio Markets, your new real-time DeSci market intel.
📖 Read here: www.bio.xyz/blog-posts/b...
From brain health clinical trials and psilocybin derivatives to Bio Markets, your new real-time DeSci market intel.
📖 Read here: www.bio.xyz/blog-posts/b...
For the first time, we can hook science into a new age of discovery fueled by social signals, AI and open networks.
Agentic systems can test endlessly, refine endlessly and search pathways we could never map alone.
For the first time, we can hook science into a new age of discovery fueled by social signals, AI and open networks.
Agentic systems can test endlessly, refine endlessly and search pathways we could never map alone.